Sandimmune 25 MG capsule UD 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FL0WZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,858
Award facts
- Contract value 100% obligated
- $1,858.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Sandimmune 25 mg capsules in unit dose packaging (30-count) with a ceiling value of $1,858.30. This firm fixed-price delivery order is non-set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999.999 billion through December 2026). The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of January 7, 2026. Sandimmune (cyclosporine) is an immunosuppressant medication commonly used in military and veterans' healthcare systems for transplant recipients and patients with autoimmune conditions.
AmerisourceBergen, now operating under parent company Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The company's DLA Troop Support Medical indefinite delivery contract serves as a comprehensive global pharmaceutical support vehicle enabling delivery of a vast range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. This delivery order exemplifies the company's role in fulfilling essential pharmaceutical needs for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through a flexible contract structure supporting military treatment facilities and veterans' programs.
Quick answers
Who was awarded contract SPE2DR26FL0WZ?
SPE2DR26FL0WZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FL0WZ worth?
The government has obligated $1,858 on SPE2DR26FL0WZ.
Is contract SPE2DR26FL0WZ an order under another contract?
Yes. SPE2DR26FL0WZ is a delivery order under SPE2DR25D3401, an indefinite delivery contract.
Was contract SPE2DR26FL0WZ competed?
The extent of competition for SPE2DR26FL0WZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award